UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 10, 2024 (September 26, 2024)

Allied Corp.

(Exact Name of Registrant as Specified in its Charter)

Nevada

0-27675

33-1227173

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

460 Doyle Ave., Kelowna BC Canada		V1Y OC2
(Address of Principal Executive Offices)		(Zip Code)

Registrant's Telephone Number, Including Area Code: (877) 255-4337

____________________________________________________

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On or about September 26, 2024 the Registrant’s wholly owned subsidiary Allied Colombia S.A.S. entered into a Forward Purchase Agreement with CanPoland Spolka Akeyina and Blossom Genetics Lda pursuant to which the Company will sell THC and CBD medical grade cannabis and related products, manufactured by Blossom Genetics Lda, to CanPoland for sale in Poland..

The foregoing description is qualified by the actual terms of the Forward Purchasing Agreement attached as an exhibit hereto.

Item 9.01 Financial Statements and Exhibits.

The following Exhibits are included herein:

Exhibit No.		Description
10.1		Forward Purchase Agreement dated September 26, 2024 between CanPoland Spółka Akcyjna ,Allied Colombia S.A.S and Blossom Genetics Lda.
104		Cover Page Interactive Data File (embedded within the Inline XBRL Document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Allied Corp. (Registrant)

Dated: October 10, 2024	By:	/s/ Calum Hughes
	Chief Executive Officer

Allied Corp. 8-K